FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

8057211000001107: Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20176901000001113 Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
53186301000001111 Biliscopin 50 infusion 100ml bottles (Bayer Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Is a Meglumine iotroxate 105mg/ml (Iodine 50mg/ml) solution for injection 100ml bottles true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has active ingredient Meglumine iotroxate false Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has active ingredient Iotroxate meglumine false Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Is a Biliscopin true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Iodine true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has specific active ingredient Iotroxate meglumine true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has active ingredient Meglumine iotroxinate false Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has basis of strength substance Iodine true Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Has active ingredient Iotroxate meglumine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) 10 bottle Is pack of False Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Inferred relationship Existential restriction modifier
Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) 10 bottle Has AMP True Biliscopin 50 infusion solution for injection 100ml bottles (Schering Health Care Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start